Side-by-side comparison
Pentadeca Arginate (PDA) vs GHRH (Growth Hormone-Releasing Hormone)
Arginate-salt analog of BPC-157 developed for improved injection stability and tissue repair. versus Native 44-aa hypothalamic GHRH; parent molecule of sermorelin, CJC-1295, and tesamorelin.
Pentadeca Arginate (PDA)
RecoveryArginate-salt analog of BPC-157 developed for improved injection stability and tissue repair.
Top benefits
- ✓Tendon and ligament healing
- ✓Better stability than BPC-157 acetate
- ✓Anti-inflammatory
GHRH (Growth Hormone-Releasing Hormone)
PerformanceNative 44-aa hypothalamic GHRH; parent molecule of sermorelin, CJC-1295, and tesamorelin.
Top benefits
- ✓Pulsatile GH release
- ✓Preserves natural HPA axis
- ✓Reference comparator for analogs
| Attribute | Pentadeca Arginate (PDA) | GHRH (Growth Hormone-Releasing Hormone) |
|---|---|---|
| Category | Recovery | Performance |
| Type | linear | linear |
| Chain length | 15 aa | 44 aa |
| Formula | BPC-157 arginate salt | C215H358N72O66S |
| Common dose | 250-500 mcg | 1 mcg/kg |
| Frequency | 1-2x daily SC | Single bolus IV |
| Top benefit | Tendon and ligament healing | Pulsatile GH release |
| Top side-effect | Injection-site irritation | Flushing |
⚠
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.